Remove Bioinformatics Remove Genetic Engineering Remove Medicine Remove Scientist
article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

Sebastian Jaeger, PhD, Senior Scientist, ADCs & Targeted NBE Therapeutics, Merck Healthcare KGaA, on: ‘Evaluation of Fcab-drug conjugates as a novel antibody-based format for targeted drug delivery’.

article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Gail Calvert, Field Application Scientist, Sartorius UK, on: ‘Leveraging integrated and advanced technologies for successful cell line development’. Engineering for higher avidity and multi-valency Following chairperson’s remarks from Bruce Keyt, PhD, CSO, R&D, IGM Biosciences, there will be three presentations in this session.